RUPP PI PDD: Drug and Behavioral Therapy for Children With Pervasive Developmental Disorders

Completed · Not applicable

Conditions studied: Child Development Disorders, Pervasive

In brief

This 24-week study will compare the safety and effectiveness of medication treatment alone (risperidone or aripiprazole) to medication treatment in combination with a parent management training program.

Key facts

Study ID

NCT00080145

Run by

Yale University

People needed

124

Starts

2004-02-01

Expected to finish

2007-09-01

Last updated by the study team

2013-08-16

Who can join

Age: 4 and older, up to 13. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Autistic Disorder, Asperger's Disorder, or Pervasive Developmental Disorder not otherwise specified
• Weight > 30 lbs
• IQ >= 35 or mental age of at least 18 months

You may not qualify if…

• Psychotic Disorder
• History of intolerance or nonresponse to risperidone
• Pregnancy
• History of neuroleptic malignant syndrome

Where it is running

• Yale University — New Haven, Connecticut, United States
• Indiana University — Indianapolis, Indiana, United States
• Ohio State University — Columbus, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.